【財華社訊】港交所權益資料顯示,藥明生物(02269.HK)獲摩根大通於05月24日在場內以每股平均價108.6527港元增持102.56萬股,涉資約1.11億港元。增持後,摩根大通的最新持股數目為3.81億股,持股比例由8.99%增持至9.02%。(出處:FinetAI)
【權益變動】藥明生物(02269.HK)獲摩根大通增持102.5564萬股
1970-01-01T00:00:00-05:00January 1st, 1970|
Related Posts
-
China tightens IPO rules for STAR Market hopefuls
May 4th, 2024 -
China’s Zeekr seeks over $5b valuation in US IPO
May 4th, 2024